The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
ASEAN Sec-Gen Highlights Japan’s Role In ASEAN’s Growth
A more integrated East Asia is needed in the era of globalization, said the ASEAN Secretary General Surin Pitsuwan.
Zinc Helps Infants Respond To Bacterial Infection Treatment, Study
A newly released clinical study conducted in India showed that zinc supplements, taken with antibiotic treatment, boosted infant survival from serious bacterial infections.
Life On Mars: Just Add Carbon And Stir
Martian meteorites that fell to Earth may contain building blocks of life, says Marion Anderson from Monash University.
Eating Blueberries May Hasten Muscle Recovery After Exercise, Study
Fruit sellers may want to stock up on New Zealand blueberries after a study found athletes who eat them recover faster from exercise.
Takeda Unveils New Treatment For Hypertension In Japan
AZILVA, a new drug from Takeda Pharmaceutical Company Limited, is now available for the treatment of hypertension in Japan.
Square Kilometer Array To Be Shared By Australasia, South Africa
The Square Kilometer Array radio telescope will be deployed in both Australia-New Zealand and South Africa, announced the international SKA Organization on Friday.
Under The Weather? New Tongue Scanning Software May Explain Why.
University of Missouri researchers have developed computer software to analyze the flow and balance of 'hot' and 'cold' zheng in the body simply by scanning one's tongue.
Takeda To Acquire Brazil’s Multilab For US$250 Million
Takeda Farmacêutica Brasil Ltda., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, is set to acquire Brazil-based Multilab for US$250 million.
One-Third Of Malaria Drugs In Southeast Asia Are Fake, Study
One-third of the malaria drugs sold across Southeast Asia are either poor quality or fake, according to a NIH study published today in The Lancet Infectious Diseases.